CA71716K1012
© PR Newswire
02.01.2026
PCLO
LISTED
TSX
Canadian Investment Regulatory Organization Trade Resumption - PCLO
News Preview
VANCOUVER, BC, Jan. 2, 2026 /CNW/ - Trading resumes in:
Company: Pharmacielo Ltd.TSX-Venture Symbol: PCLOAll Issues: YesResumption (ET): 9:30 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the nation...
Themefolio
Profiler
Peergroup
© Newsfile
30.12.2025
PCLO
LISTED
TSX
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 30, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts,...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
PCLO
LISTED
TSX
PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
News Preview
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
28.02.2025
PCLO
LISTED
TSX
PharmaCielo Reports Q4 2024 Financial Results
News Preview
PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million.Revenues and Gross Profit Margin Increased with More Diverse Customer Base.Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs.Financial Year-E...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
12.02.2025
PCLO
LISTED
TSX
PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - February 12, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts,...
Themefolio
Profiler
Peergroup
© Newsfile
02.12.2024
PCLO
LISTED
TSX
PharmaCielo Reports Q3 2024 Financial Results
News Preview
PharmaCielo achieved 85% Year-Over-Year Sales Growth, Generating Year-to-Date Q3 Total Revenue of $2.4 MillionQ3 Gross Profit Turned Positive Reflecting More Diverse Customer BaseQ3 Cash Flow Improved and EBITDA Increased by $0.8 Million Reflecting Strong Sales Growth and Reduced CostsToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - Decem...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2024
PCLO
LISTED
TSX
PharmaCielo Announces Intention to Extend Expiry Date of Warrants
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 5, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2024
PCLO
LISTED
TSX
PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 7, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaC...
Themefolio
Profiler
Peergroup
© Newsfile
16.08.2024
PCLO
LISTED
TSX
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 16, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaC...
Themefolio
Profiler
Peergroup
© Newsfile
17.07.2024
PCLO
LISTED
TSX
CORRECTION FROM SOURCE: PharmaCielo Provides Update on Reinstatement for Trading
News Preview
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today provided shareholders with...
Themefolio
Profiler
Peergroup
© Newsfile
17.07.2024
PCLO
LISTED
TSX
PharmaCielo Provides Update on Reinstatement for Trading
News Preview
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today provided shareholders with...
Themefolio
Profiler
Peergroup
© Newsfile
04.07.2024
PCLO
LISTED
TSX
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, Pharm...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
08.05.2024
PCLO
LISTED
TSX
PharmaCielo Announces Issuance of Failure to File Cease Trade Order
News Preview
All amounts expressed in Canadian dollars unless otherwise notedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo...
Themefolio
Profiler
Peergroup
© Newsfile
10.04.2024
PCLO
LISTED
TSX
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors
News Preview
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product.Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, will join the Company's board of directors on closing./NOT F...
Themefolio
Profiler
Peergroup
© Newsfile
26.03.2024
PCLO
LISTED
TSX
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
News Preview
The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to 1.871 tons of pharma-grade CBD to the government over a 12-month period. Ease Labs' product is based on PharmaCielo's proprietary API.Toronto,...
Themefolio
Profiler
Peergroup
© Newsfile
01.03.2024
PCLO
LISTED
TSX
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo
News Preview
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today commented on the...
Themefolio
Profiler
Peergroup
© Newsfile
04.01.2024
PCLO
LISTED
TSX
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
News Preview
Austin, Texas and Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - January 4, 2024) - Benuvia Operations, LLC ("Benuvia"), a FDA registered, DEA licensed and cGMP certified leader in pharmaceutical cannabinoids, and PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"), the Canadian parent of Colombia's premier cultivator, producer...
Themefolio
Profiler
Peergroup
© Newsfile
29.11.2023
PCLO
LISTED
TSX
PharmaCielo Announces Q3 2023 Financial Results
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCi...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2023
PCLO
LISTED
TSX
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
News Preview
Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000.The Company also announced that it has agreed to issue shares and debt in settlement of certain amounts owing.Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 6, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCi...
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2023
PCLO
LISTED
TSX
PharmaCielo Announces Q2 2023 Financial Results
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCiel...
Themefolio
Profiler
Peergroup
© Newsfile
10.08.2023
PCLO
LISTED
TSX
PharmaCielo Provides Corporate Update
News Preview
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 10, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today provided shareh...
Themefolio
Profiler
Peergroup
© Newsfile
11.07.2023
PCLO
LISTED
TSX
PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO
News Preview
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced that Ma...
Themefolio
Profiler
Peergroup
© Newsfile
29.06.2023
PCLO
LISTED
TSX
PharmaCielo Provides Corporate Update
News Preview
PharmaCielo is actively working with more than 24 customers in 15 countries globally, with a focus on psychoactive APIs and dried flower.The Company recently made its first shipment of THC Distillate and THC-Dominant Dried Flower to a customer in Australia that will be supplying these products to dispensaries across the country.The Company has clos...
Themefolio
Profiler
Peergroup
© Newsfile
29.05.2023
PCLO
LISTED
TSX
PharmaCielo Announces Q1 2023 Financial Results
News Preview
The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year.Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million.PharmaCielo continues to focus on operating efficiently, with overhead expensesi down 20% from Q1 of 2022, and a recently initiated...
Themefolio
Profiler
Peergroup
© Newsfile
16.05.2023
PCLO
LISTED
TSX
PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in South Africa
News Preview
Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia'...
Themefolio
Profiler
Peergroup
© Newsfile
01.05.2023
PCLO
LISTED
TSX
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2022
News Preview
During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023.The Company's measured investments in revenue-generating sales channels resulted in revenues of $5.3 million in 2022, almost three-times more than the $1.9 million reported in 2021.Consistent progress on streamlining the business, to move t...
Themefolio
Profiler
Peergroup
© Newsfile
19.04.2023
PCLO
LISTED
TSX
PharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis Market
News Preview
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time.Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients in Europe the highest quality high-THC flower product currently available in the market.Toronto, Ontario and Ri...
Themefolio
Profiler
Peergroup
© Newsfile
01.05.2020
PCLO
LISTED
TSX
PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - May 1, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2020
PCLO
LISTED
TSX
PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
News Preview
New York, New York--(Newsfile Corp. - April 29, 2020) - Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi &...
Themefolio
Profiler
Peergroup
© Newsfile
28.04.2020
PCLO
LISTED
TSX
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PharmaCielo Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
News Preview
Los Angeles, California--(Newsfile Corp. - April 28, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Themefolio
Profiler
Peergroup
© Newsfile
28.04.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - April 28, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. ("PharmaCielo" or the "Company") (OTCQX: PCLOF) of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
24.04.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
News Preview
New York, New York--(Newsfile Corp. - April 24, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
10.04.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - April 10, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Comp...
Themefolio
Profiler
Peergroup
© Newsfile
07.04.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - April 7, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Compa...
Themefolio
Profiler
Peergroup
© Newsfile
03.04.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - April 3, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
26.03.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
News Preview
New York, New York--(Newsfile Corp. - March 26, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
20.03.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
News Preview
New York, New York--(Newsfile Corp. - March 20, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
18.03.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
News Preview
New York, New York--(Newsfile Corp. - March 18, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
16.03.2020
PCLO
LISTED
TSX
PHARMACIELO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - March 16, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Fa...
Themefolio
Profiler
Peergroup
© Newsfile
12.03.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - March 12, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Themefolio
Profiler
Peergroup
© Newsfile
10.03.2020
PCLO
LISTED
TSX
PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
News Preview
New York, New York--(Newsfile Corp. - March 10, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. F...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
